Share-based Payment Arrangement, Expense of Quoin Pharmaceuticals, Ltd. from 31 Dec 2021 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Quoin Pharmaceuticals, Ltd. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Dec 2021 to 30 Sep 2025.
  • Quoin Pharmaceuticals, Ltd. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $182,000, a 42% decline year-over-year.
  • Quoin Pharmaceuticals, Ltd. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $1,191,000, a 3% decline year-over-year.
  • Quoin Pharmaceuticals, Ltd. annual Share-based Payment Arrangement, Expense for 2024 was $1,260,000, a 16% increase from 2023.
  • Quoin Pharmaceuticals, Ltd. annual Share-based Payment Arrangement, Expense for 2023 was $1,090,000, a 43% increase from 2022.
  • Quoin Pharmaceuticals, Ltd. annual Share-based Payment Arrangement, Expense for 2022 was $764,000.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Quoin Pharmaceuticals, Ltd. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $1,191,000 $182,000 -$131,000 -42% 01 Jul 2025 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 $1,322,000 $321,000 +$8,000 +2.6% 01 Apr 2025 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $1,314,000 $360,000 +$54,000 +18% 01 Jan 2025 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q4 2024 $1,260,000 $328,000 +$32,000 +11% 01 Oct 2024 31 Dec 2024 10-K 13 Mar 2025 2024 FY
Q3 2024 $1,228,000 $313,000 +$44,000 +16% 01 Jul 2024 30 Sep 2024 10-Q 06 Nov 2025 2025 Q3
Q2 2024 $1,184,000 $313,000 +$49,000 +19% 01 Apr 2024 30 Jun 2024 10-Q 07 Aug 2025 2025 Q2
Q1 2024 $1,135,000 $306,000 +$45,000 +17% 01 Jan 2024 31 Mar 2024 10-Q 13 May 2025 2025 Q1
Q4 2023 $1,090,000 $296,000 01 Oct 2023 31 Dec 2023 10-K 13 Mar 2025 2024 FY
Q3 2023 $269,000 +$2,000 +0.75% 01 Jul 2023 30 Sep 2023 10-Q 08 Nov 2024 2024 Q3
Q2 2023 $264,000 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024 2024 Q2
Q1 2023 $261,000 +$261,000 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q1
Q3 2022 $267,000 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023 2023 Q2
Q1 2022 $0 01 Jan 2022 31 Mar 2022 10-Q 09 May 2023 2023 Q1

Quoin Pharmaceuticals, Ltd. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $1,260,000 +$170,000 +16% 01 Jan 2024 31 Dec 2024 10-K 13 Mar 2025 2024 FY
2023 $1,090,000 +$326,000 +43% 01 Jan 2023 31 Dec 2023 10-K 13 Mar 2025 2024 FY
2022 $764,000 +$764,000 01 Jan 2022 31 Dec 2022 10-K 14 Mar 2024 2023 FY
2021 $0 01 Jan 2021 31 Dec 2021 10-K 15 Mar 2023 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.